Recursion to Participate in Upcoming Investor Conference
Recursion (RXRX), a clinical stage TechBio company focused on drug discovery, has announced its upcoming participation in the Needham 24th Annual Virtual Healthcare Conference scheduled for April 7, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Recursion (RXRX), a clinical stage TechBio company focused on drug discovery, has announced its upcoming participation in the Needham 24th Annual Virtual Healthcare Conference scheduled for April 7, 2025.
Investors and interested parties can access the conference webcasts through the events section of Recursion's Investor Relations website at ir.recursion.com.
Details
News Market Reaction – RXRX
The recorded move for RXRX in the trading session of this news was -3.69%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference:
- Needham 24th Annual Virtual Healthcare Conference — Monday, April 7, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Media Contact Media@Recursion.com Investor Contact Investor@Recursion.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.